Issued Patents All Time
Showing 1–25 of 198 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12415856 | EGFR x CD28 multispecific antibodies | Dimitris Skokos, Andrew J. Murphy, Chia-Yang Lin, Lauric Haber | 2025-09-16 |
| 12402611 | Genetically modified mice and engraftment | Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan +3 more | 2025-09-02 |
| 12268730 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2025-04-08 |
| 12251440 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Robert Babb, Alina BAUM, Gang Chen, Cindy Gerson, Johanna Hansen +7 more | 2025-03-18 |
| 12162943 | High affinity human antibodies to human IL-4 receptor | Joel H. Martin, Tammy T. Huang, Jeanette L. Fairhurst, Nicholas J. Papadopoulos | 2024-12-10 |
| 12127537 | Genetically modified non-human animals and methods of use thereof | Richard Flavell, Markus Manz, Anthony Rongvaux, Till Strowig, Tim Willinger +2 more | 2024-10-29 |
| 12127536 | Humanized M-CSF mice | Andrew J. Murphy, Sean Stevens, Chozhavendan Rathinam, Elizabeth Eynon, Markus Manz +1 more | 2024-10-29 |
| 12037596 | Targeted modification of rat genome | Jeffrey D. Lee, Alexander O. Mujica, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2024-07-16 |
| 11986511 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2024-05-21 |
| 11975045 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2024-05-07 |
| 11964016 | Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy | Seblewongel ASRAT, Andre Limnander, Jamie M. Orengo, Andrew J. Murphy | 2024-04-23 |
| 11912767 | EGFR × CD28 multispecific antibodies | Dimitris Skokos, Andrew J. Murphy, Chia-Yang Lin, Lauric Haber | 2024-02-27 |
| 11866503 | Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor | Jamie M. Orengo, Jeanne Allinne, Andrew J. Murphy | 2024-01-09 |
| 11820997 | Methods and compositions for the targeted modification of a genome | David Frendewey, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2023-11-21 |
| 11778995 | Genetically modified non-human animals and methods of use thereof | Richard Flavell, Till Strowig, Markus Manz, Chiara Borsotti, Madhav Dhodapkar +2 more | 2023-10-10 |
| 11732030 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Robert Babb, Alina BAUM, Gang Chen, Cindy Gerson, Johanna Hansen +7 more | 2023-08-22 |
| 11730794 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2023-08-22 |
| 11707506 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2023-07-25 |
| 11697828 | Methods and compositions for targeted genetic modification using paired guide RNAs | David Frendewey, Ka-Man Venus Lai, Wojtek Auerbach, Gustavo Droguett, Anthony Gagliardi +4 more | 2023-07-11 |
| 11576356 | Genetically modified non-human animals and methods of use thereof | Dietmar Herndler-Brandstetter, Richard Flavell, Davor Frleta, Cagan Gurer, Markus Manz +6 more | 2023-02-14 |
| 11559564 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2023-01-24 |
| 11548947 | Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof | Andrew J. Murphy, Dimitris Skokos, Janelle Waite, Erica Ullman, Aynur Hermann +2 more | 2023-01-10 |
| 11453721 | Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof | Andrew J. Murphy, Dimitris Skokos, Janelle Waite, Erica Ullman, Aynur Hermann +3 more | 2022-09-27 |
| 11396544 | Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof | Andrew J. Murphy, Dimitris Skokos, Janelle Waite, Erica Ullman, Aynur Hermann +3 more | 2022-07-26 |
| 11352417 | Method of treating an allergy with allergen-specific monoclonal antibodies | Jamie M. Orengo, Namita A. Gandhi, Allen Radin, Ana Kostic, Andrew J. Murphy | 2022-06-07 |